SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

2.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

3.

Prostate cancer early detection system eliminates need for biopsy.

4.

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

5.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot